Pneumonia in Older Residents of Long-Term Care Facilities
Am Fam Physician. 2004 Oct 15;70(8):1495-1500.
This article exemplifies the AAFP 2004 Annual Clinical Focus on caring for America’s aging population.
Compared with community-dwelling persons, residents in long-term care facilities have more functional disabilities and underlying medical illnesses and are at increased risk of acquiring infectious diseases. Pneumonia is the leading cause of morbidity and mortality in this group. Risk factors include unwitnessed aspiration, sedative medication, and comorbidity. Recognition may be delayed because, in this population, pneumonia often presents without fever, cough, or dyspnea. Accurate identification of the etiologic agent is hampered because most patients cannot produce a suitable sputum specimen. It is difficult to distinguish colonization from infection. Colonization by Staphylococcus aureus and gram-negative organisms can result from aspiration of oral or gastric contents, which could lead to pneumonia. Aspiration of gastric contents also can produce aspiration pneumonitis. This condition is not infectious initially and may resolve without antibiotics. Antibiotics for the treatment of pneumonia should cover Streptococcus pneumoniae, Haemophilus influenzae, gram-negative rods, and S. aureus. Acceptable choices include quinolones or an extended-spectrum beta-lactam plus a macrolide. Treatment should last 10 to 14 days. Pneumonia is associated with significant mortality for up to two years. Dementia is related independently to the death rate within the first week after pneumonia, regardless of treatment. Prevention strategies include vaccination against S. pneumoniae and influenza on admission to the care facility. This article focuses on recent recommendations for the recognition of respiratory symptoms and criteria for the designation of probable pneumonia, and provides a guide to hospitalization, antibiotic use, and prevention.
The number of frail older adults living in long-term care (LTC) facilities is expected to increase dramatically over the next 30 years.1 An estimated 40 percent of adults will spend some time in an LTC facility before dying.2 Because residents of these facilities have higher levels of functional disability and underlying medical illness than older adults in the community, they are at increased risk of acquiring infectious diseases.3
Strength of Recommendation
Strength of Recommendation
|Key clinical recommendations||Label||References|
Residents of long-term care (LTC) facilities should be vaccinated against Streptococcus pneumoniae.
All residents of LTC facilities should receive influenza vaccine.
Residents of LTC facilities who are being hospitalized should receive one dose of parenteral antibiotics immediately before leaving the facility unless it would delay transport for more than one hour. The hospital should be notified of the antibiotic given.
A single dose of antibiotics should be ordered immediately (simultaneously with chest radiograph) if the care facility resident has any of the following: systolic blood pressure < 90 mm Hg or 20 mm Hg less than baseline; oxygen saturation < 90 percent on room air at sea level; pulse < 130 beats per minute; respiratory rate μ 30 breaths per minute; or temperature μ 38.6°C (101.5ºF).
In LTC facility residents with probable pneumonia who are stable (oxygen saturation μ 90 percent, systolic blood pressure μ 90 mm Hg, pulse < 120 beats per minute, and respiratory rate < 30 breaths per minute), the decision to use antibiotics may await results of the chest radiograph if it can be available within 24 hours. If the chest radiograph does not confirm the suspicion of pneumonia, consideration should be given to stopping antibiotic treatment.
Antibiotics should be delivered to the LTC facility resident within four hours of the physician’s order.
If the LTC resident is able to take oral medication, that route is preferred. However, residents being sent to the hospital should be given one parenteral dose.
*— Also recommended in the Guide to clinical preventive services: report of the U.S. Preventive Services Task Force. 2d ed. Baltimore: Williams & Wilkins, 1996.
Pneumonia is the leading cause of morbidity and mortality in this population. It also is the leading reason for transfer to acute-care facilities.4–6 At a median incidence rate of 1 to 1.2 per 1,000 patient-days,4,7 residents of LTC facilities develop pneumonia approximately 10 times more frequently than older adults in the community.3 Their hospitalization rate is reported to be nearly 30 times higher.8
LTC facilities include a variety of residences that provide care for patients with biologic and psychologic disabilities. Because nursing homes are the most numerous and best described of the LTC facilities, studies frequently use the terms “nursing homes” and “LTC facilities” interchangeably.9 This article will continue that practice.
As the population of older adults grows, the LTC facility will become an increasingly important site for medical care. There is little agreement, however, about the evaluation and management of nursing home–acquired pneumonia.3 This article summarizes recent literature on the diagnosis, treatment, and prevention of pneumonia in older persons who live in LTC facilities.
The diagnosis and prevention of pneumonia in LTC facilities requires the identification and recognition of risk factors. Past retrospective studies have yielded conflicting information.7 A recent prospective cohort study reported that older age, male sex, swallowing difficulty, and inability to take oral medications were significant risk factors.7 A prospective, case-control study that focused on modifiable factors reported that unwitnessed aspiration, sedative medication, and the number of comorbidities were associated significantly with pneumonia.5
A number of factors may increase the risk of pneumonia and of cross-transmission of pathogens among LTC residents. Individual factors include malnutrition, long-term disease, functional impairment, medications, invasive devices, and prolonged antimicrobial exposure. Institutional factors include larger facilities with a single nursing unit or multiple units with shared nursing staff, group activities, low immunization rates, excessive anti-microbial use, and widespread colonization of residents with antimicrobial-resistant organisms.1
The etiology of most cases of nursing home–acquired pneumonia is undetermined.10 Barriers preventing accurate microbial testing include the inability of most patients to produce a sputum specimen suitable for analysis, and the difficulty of distinguishing between colonization and infection in viable specimens.4,8,10,11 Frequently, patients have received empiric oral antibiotic treatment before specimens for diagnostic testing are obtained.12
To date, no multicenter studies have used standardized definitions and comprehensive testing to establish the etiology of nursing home–acquired pneumonia.12 This inconsistency is reflected in a wide range of results. In a 1998 survey of published studies, Streptococcus pneumoniae was identified in zero to 39 percent of specimens, Staphylococcus aureus in zero to 33 percent, and gram-negative bacteria in zero to 55 percent.4 A recent study listed agents commonly associated with pneumonia in older adults living in the community or in LTC facilities (Table 1).12 The potential relationship between unrecognized aspiration of oral or gastric contents and the subsequent development of pneumonia in older adults is receiving more attention. An association has been reported between dysphagia and increased oropharyngeal colonization with bacteria including S. aureus and gram-negative bacilli such as Klebsiella pneumoniae and Escherichia coli. Such colonization potentially could lead to aspiration pneumonia.13 Pseudomonas aeruginosa has been isolated from 34 percent of nasogastric tube–fed older hospitalized patients but from none of the orally fed control group. Other gram-negative organisms were isolated from 64 percent of tube-fed patients and from only 8 percent of the control group. Thus, the oropharynx of tube-fed patients could be a potential reservoir for P. aeruginosa.14
TABLE 1 Causative Agents of Pneumonia in Older Adults
Causative Agents of Pneumonia in Older Adults
*— Less frequently documented in older adults who reside in long-term care facilities.
Adapted with permission from Loeb M. Pneumonia in older persons. Clin Infect Dis 2003;37:1336.
A recent study examined the relationship between strictly defined aspiration events and outcome in patients hospitalized with suspected pneumonia.15 Results showed that aspiration pneumonitis, subsequent to gastric aspiration, occurred twice as often as pneumonia. Although the condition is not infectious in its initial stages, the authors report that physicians tend to treat aspiration pneumonitis with antibiotics. They report that many episodes of aspiration pneumonitis resolve with supportive care alone, and that the mortality related to this condition may differ from the mortality related to infectious pneumonia. If confirmed, this finding could have important implications for the diagnosis and management of suspected pneumonia.15
In an earlier study of nursing home–acquired pneumonia, rapid identification of respiratory symptoms followed by prompt response, appropriate antibiotic usage, and hospitalization when indicated led to improved survival.11 Subsequently, the authors of this study convened a national multidisciplinary, multispecialty panel (Hutt Kramer panel) of experts to develop comprehensive, evidence-based guidelines for the management of nursing home–acquired pneumonia. In 2003, the panel evaluated the published literature and graded each recommendation according to a standard system, using three categories for the strength of evidence: A (good); B (moderate); and C (poor).11 We have translated those ratings to the strength-of-recommendation taxonomy labels used in this journal.
As noted, prompt recognition of nursing home–acquired pneumonia and rapid institution of antibiotic therapy is associated with improved outcomes. Recommendations for recognition and physician notification of serious respiratory symptoms are presented in Table 2.11 Criteria for a diagnosis of “probable pneumonia” are presented in Table 3.11
TABLE 2 Recommendations for Recognition and Physician Notification of Serious Respiratory Symptoms
Recommendations for Recognition and Physician Notification of Serious Respiratory Symptoms
Physicians caring for long-term care residents should be available or offer cross-coverage by pager 24 hours a day, seven days a week.
Staff should page the physician within one hour when a resident is noted to have any two of the following signs or symptoms: new or worsening cough; increased or newly purulent sputum; decline in cognitive, physical, or functional status; fever; hypothermia; dyspnea; tachypnea; chest pain; new or worsening hypoxemia.
Evaluation at symptom onset should include vital signs (temperature, pulse rate, respiratory rate, and blood pressure) and oxygen saturation if a pulse oximeter is available.
When notified, the physician should call back within one hour.
If the care facility staff has not heard from the physician within one hour, the director of nurses (or a designee) should be notified; this person is responsible for asking the medical director (or a designee) to assume care of the resident until the medical director can contact the attending physician.
TABLE 3 Criteria for Diagnosis of Probable Pneumonia
Criteria for Diagnosis of Probable Pneumonia
The physician and facility staff should agree that pneumonia is a possible cause of a change in respiratory status if the patient has two or more of the following signs or symptoms:
New or worsening cough
Newly purulent sputum
Temperature of 38.1°C (100.5°F), < 35.6°C (96°F), or 1.1°C (2°F) more than baseline
Respiratory rate = 25 breaths per minute
New or worsening hypoxia
Pleuritic chest pain
Decline in cognitive or functional status
Physical findings on chest examination such as rales or rhonchi
Because nursing home–acquired pneumonia often is the terminal event of a long and debilitating illness, the decision to hospitalize a resident is especially important.11 However, there are no defined criteria for determining which residents should be hospitalized.1,15 Although one study suggested that treatment in the facility without hospitalization is beneficial,16 there is little research to support that conclusion.6 In the absence of standards for hospitalization, it is difficult to evaluate and compare outcome studies. Negative aspects of hospital transfer include physical discomfort, disorientation, and exposure to additional problems such as delirium, falls, incontinence, dehydration, adverse drug effects, and nosocomial infections.17 Prospective studies to determine which residents would benefit from hospitalization for the treatment of nursing home–acquired pneumonia are needed.18
The Hutt Kramer panel recommends that the patient’s desire for hospitalization and aggressive care be assessed directly, if possible, or by chart review or discussion with the patient’s health care surrogate. Patients with orders for no hospitalization and those who refuse hospitalization, personally or through a surrogate, should not be hospitalized.11 The panel’s recommendations to guide decision making for patients willing to be hospitalized are presented in Table 4.11
TABLE 4 Guide for Hospitalizing Willing Patients
Guide for Hospitalizing Willing Patients
Patients with two or more of the following symptoms should be hospitalized:
Oxygen saturation < 90% on room air at sea level
Systolic blood pressure < 90 mm Hg or 20 mm Hg less than baseline
Respiratory rate > 30 breaths per minute or 10 breaths per minute more than baseline
Requiring 3 L per minute of oxygen more than baseline
Uncontrolled chronic obstructive pulmonary disease, congestive heart failure, or diabetes mellitus
Unarousable if previously conscious
New or increased agitation
If the facility cannot provide vital sign assessment every four hours, laboratory access, parenteral hydration, and two licensed nurses per shift, consideration should be given to hospitalizing patients who have only one of the listed symptoms.
Patients with none of the listed symptoms should be treated in the care facility unless the patient or a surrogate insists on hospitalization.
11Information from reference 11.
In comparison with community-acquired pneumonia, far fewer studies address the management of nursing home–acquired pneumonia.3,12 In 2000, members of the Society for Healthcare Epidemiology of America (SHEA) formulated minimum criteria for the empiric initiation of antibiotics in clinically stable residents of LTC facilities with signs and symptoms of bacterial infection. They focused on the broader category of lower respiratory illnesses, which includes pneumonia and other lower respiratory tract infections.12
The following year, the Hutt Kramer panel published guidelines that focused specifically on pneumonia.11 They list five recommendations for antibiotic use, which do not conflict with recently published guidelines on use of antibiotics in LTC facilities.
The SHEA group and the Hutt Kramer panel disagree about the choice of specific antibiotics. The differences involve three key factors: the relative importance of gram-negative rods as etiologic versus colonizing organisms in nursing home–acquired pneumonia; the relative importance of atypical organisms; and concern that an important percentage of bacteria in LTC facilities already may be resistant to many of the antibiotics endorsed by the SHEA group. The Hutt Kramer panel cites studies suggesting that broader spectrum empiric treatment of nursing home–acquired pneumonia provides a survival benefit.11 The panel’s recommendations include the following: antibiotics chosen as empiric therapy should cover S. pneumoniae, Haemophilus influenzae, gram-negative rods, and S. aureus; acceptable choices for empiric treatment are antipneumococcal quinolones or an extended-spectrum beta-lactam plus a macrolide; and treatment should last for 10 to 14 days.
Because some LTC residents are chronically ill and nearing the end of life, physicians should consider severity of illness when making treatment decisions. The scoring system presented in Table 519 identifies patient characteristics that predict 30-day mortality in LTC residents with lower respiratory tract infections. Scores are assigned the following mortality risk, with the risk percentage that comes from a prospective validation of the score: 1 to 4 (low, 1.8 percent); 5 to 6 (relatively low, 5.0 percent); 7 to 8 (moderate, 11.6 percent); 9 to 10 (high, 25.0 percent); and 11 to 17 (very high, 54.2 percent).19
Scoring System for Estimating 30-Day Mortality from Lower Respiratory Tract Infection*
The rightsholder did not grant rights to reproduce this item in electronic media. For the missing item, see the original print version of this publication.
A prospective case-control study found that an episode of nursing home–acquired pneumonia is associated with significant mortality that persists for up to two years. Two risk factors—large-volume aspiration and sedating medication—are potentially modifiable.5 The degree of dementia also is related independently to mortality attributed to nursing home–acquired pneumonia after controlling for age, comorbidity, sex, and type of treatment, including antibiotics. In addition, dementia severity was independently related to the death rate within the first week after pneumonia. The functional and pathophysiologic consequences of progressive dementia account in part for an increased three-month mortality after pneumonia, irrespective of aspiration or weight loss.20 These findings highlight the need for advance care planning with patients and their health care surrogates, if possible, particularly about choices for treatment.
Prevention of pneumonia in LTC facilities focuses on recognizing and modifying risk factors. These include the immunization rate, potentials for cross-transmission of pathogens during group activities and resident–health care worker interactions, and the potential for development of antimicrobial-resistant bacteria from widespread empiric use of antimicrobial therapy.
The guidelines from the Hutt Kramer panel state that residents should be vaccinated against S. pneumoniae at admission unless there is documentation of vaccination within five years before admission or of an allergic response to previous pneumococcal vaccine; residents should be vaccinated against influenza by December of each year if they are not allergic to eggs or previous influenza vaccines; residents admitted between December and March should be vaccinated if they are not already immunized for the current influenza season and are not allergic; and the facility should provide and strongly recommend influenza immunization for all employees by December of each year if the employee is not allergic to eggs or previous vaccines.11
Standard precautions by staff also are thought to have an impact on the transmission of antimicrobial-resistant organisms.2 Precautions include glove use for contact with blood and body fluids and good hand hygiene. While the use of isolation and barrier precautions with colonized residents has not been shown to reduce infections from antimicrobial-resistant organisms consistently, new guidelines are being developed through the sponsorship of the Centers for Disease Control and Prevention that specifically address isolation in LTC facilities. Many state and local health departments also have developed isolation guidelines.2
Infections acquired in LTC facilities have a major effect on morbidity, mortality, human suffering, and health care costs. It is likely that the anticipated growth in the older adult population will be accompanied by an increased need for long-term care. Improving the prevention and management of infections must become a priority if the quality of care in these facilities is to be improved.1
Members of various family medicine departments develop articles for “Practical Therapeutics.” This article is one in a series coordinated by the Department of Family and Geriatric Medicine at the University of Louisville School of Medicine, Louisville, Ky. Guest editor of the series is James G. O’Brien, M.D.
1. Richards C. Infections in residents of long-term care facilities: an agenda for research. Report of an expert panel. J Am Geriatr Soc. 2002;50:570–6.
2. Richards CL Jr, Steele L. Antimicrobial-resistant bacteria in long-term care facilities: infection control considerations. J Am Med Dir Assoc. 2003;4(3 suppl):S110–4.
3. Muder RR. Approach to the problem of pneumonia in long-term care facilities. Compr Ther. 2000;26:255–62.
4. Muder RR. Pneumonia in residents of long-term care facilities: epidemiology, etiology, management, and prevention. Am J Med. 1998;105:319–30.
5. Vergis EN, Brennen C, Wagener M, Muder RR. Pneumonia in long-term care: a prospective case-control study of risk factors and impact on survival. Arch Intern Med. 2001;161:2378–81.
6. Binder EF, Kruse RL, Sherman AK, Madsen R, Zweig SC, D’Agostino R, et al. Predictors of short-term functional decline in survivors of nursing home-acquired lower respiratory tract infection. J Gerontol A Biol Sci Med Sci. 2003;58:60–7.
7. Loeb M, McGeer A, McArthur M, Walter S, Simor AE. Risk factors for pneumonia and other lower respiratory tract infections in elderly residents of long-term care facilities. Arch Intern Med. 1999;159:2058–64.
8. Marrie TJ. Pneumonia in the long-term-care facility. Infect Control Hosp Epidemiol. 2002;23:159–64.
9. Strausbaugh LJ, Joseph CL. The burden of infection in long-term care. Infect Control Hosp Epidemiol. 2000;21:674–9.
10. Medina-Walpole AM, Katz PR. Nursing home-acquired pneumonia. J Am Geriatr Soc. 1999;47:1005–15.
11. Hutt E, Kramer AM. Evidence-based guidelines for management of nursing home-acquired pneumonia. J Fam Pract. 2002;51:709–16.
12. Loeb M. Pneumonia in older persons. Clin Infect Dis. 2003;37:1335–9.
13. Marik PE, Kaplan D. Aspiration pneumonia and dysphagia in the elderly. Chest. 2003;124:328–36.
14. Leibovitz A, Dan M, Zinger J, Carmeli Y, Habot B, Segal R. Pseudomonas aeruginosa and the oropharyngeal ecosystem of tube-fed patients. Emerg Infect Dis. 2003;9:956–9.
15. Mylotte JM, Goodnough S, Naughton BJ. Pneumonia versus aspiration pneumonitis in nursing home residents: diagnosis and management. J Am Geriatr Soc. 2003;51:17–23.
16. Fried TR, Gillick MR, Lipsitz LA. Short-term functional outcomes of long-term care residents with pneumonia treated with and without hospital transfer. J Am Geriatr Soc. 1997;45:302–6.
17. Ouslander JG, Weinberg AD, Phillips V. Inappropriate hospitalization of nursing facility residents: a symptom of a sick system of care for frail older people. J Am Geriatr Soc. 2000;48:230–1.
18. Mylotte JM. Nursing home-acquired pneumonia. Clin Infect Dis. 2002;35:1205–11.
19. Mehr DR, Binder EF, Kruse RL, Zweig SC, Madsen R, Popejoy L, et al. Predicting mortality in nursing home residents with lower respiratory tract infection: the Missouri LRI study. JAMA. 2001;286:2427–36.
20. Van der Steen JT, Ooms ME, Mehr DR, van der Wal G, Ribbe MW. Severe dementia and adverse outcomes of nursing home-acquired pneumonia: evidence for mediation by functional and pathophysiological decline. J Am Geriatr Soc. 2002;50:439–48.
Copyright © 2004 by the American Academy of Family Physicians.
This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. Contact firstname.lastname@example.org for copyright questions and/or permission requests.
Want to use this article elsewhere? Get Permissions